ARCHIVES

FDA, NCI, Congress Shape Pediatric Drug Development Proposals

This article is from The Cancer Letter archive.

Vol. 29 No. 15 | April 11, 2003

Download PDF Visit The Full Archive

Related Articles

Aranesp Improved Anemia In MDS In Phase II Trial

September 30, 2005

In Brief: NCAB Will Consider Holding “Circuit Rider” Meetings; Kaplan Asked to Speak On Hybridomas

May 1, 1981

In Brief: Francis Giles named deputy director of Lurie Cancer Center

October 17, 2014

BRCA1 and BRCA2 Mutations Linked To Higher Survival

January 27, 2012

Senate Committee Investigating Pharma’s “Educational Grants.”

January 20, 2006

NCI Plans Phase-Out Of K04 Career Awards

March 3, 1995